×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
BMRA – biomerica, inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
BMRA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/25
08:32 am
bmra
Biomerica's inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS [Yahoo! Finance]
Low
Report
Biomerica's inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS [Yahoo! Finance]
11/25
08:19 am
bmra
Biomerica’s inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS
Medium
Report
Biomerica’s inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS
11/6
08:19 am
bmra
Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand
Medium
Report
Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand
10/16
08:19 am
bmra
Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica’s inFoods® IBS Test in the U.S.
Neutral
Report
Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica’s inFoods® IBS Test in the U.S.
10/15
09:27 am
bmra
Biomerica Reports First Quarter Fiscal 2026 Financial Results
Medium
Report
Biomerica Reports First Quarter Fiscal 2026 Financial Results
10/8
08:45 am
bmra
Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors [Yahoo! Finance]
Low
Report
Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors [Yahoo! Finance]
10/8
08:19 am
bmra
Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors
Low
Report
Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors
9/9
08:28 am
bmra
Biomerica Launches AI-Backed inFoods® IBS Trigger Food Navigator to Support Personalized IBS Therapy and Improve Patient Outcomes [Yahoo! Finance]
Low
Report
Biomerica Launches AI-Backed inFoods® IBS Trigger Food Navigator to Support Personalized IBS Therapy and Improve Patient Outcomes [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
10/20
06:49 pm
bmra
Form DEF 14A BIOMERICA INC For: Dec 12
Neutral
Report
Form DEF 14A BIOMERICA INC For: Dec 12
10/14
05:11 pm
bmra
Form 10-Q BIOMERICA INC For: Aug 31
Low
Report
Form 10-Q BIOMERICA INC For: Aug 31
10/9
05:15 pm
bmra
Form PRE 14A BIOMERICA INC For: Oct 09
Medium
Report
Form PRE 14A BIOMERICA INC For: Oct 09
10/8
08:20 am
bmra
Form 8-K BIOMERICA INC For: Oct 07
Low
Report
Form 8-K BIOMERICA INC For: Oct 07
9/26
05:16 pm
bmra
Form 10-K/A BIOMERICA INC For: May 31
Low
Report
Form 10-K/A BIOMERICA INC For: May 31
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/17
Biomerica Begins Shipping Samples of 10 Minute Test for COVID-19 Virus Exposure
334.6%
3/22 Labs race to produce tests that show where COVID-19 has already been [Toronto Globe and Mail (Ontario, Canada)] 35.8%
10/15 Q1/2020 8/31/2019 EPS -0.050 ZacksConsensus -0.060 ActVsEst 0.010 - Beat 9.7%
6/5 Biomerica signs exclusive distribution agreement in China for its colorectal screening test with total minimum purchase requirement of $17 million over 7 years and an upfront pre-payment of $1 million. 8.0%
3/4 Form SC 13D BIOMERICA INC Filed by: Palm Management (US) LLC 6.1%
9/11 Biomerica, Inc. (NASDAQ: BMRA) was given a new $6.00 price target on by analysts at B. Riley. They now have a "buy" rating on the stock. 6.1%
12/30 Biomerica, Inc. (NASDAQ: BMRA) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 5.4%
4/3 Form 4 BIOMERICA INC For: Apr 01 Filed by: BARBIERI ALLEN 3.0%
1/9 Form 8-K BIOMERICA INC For: Jan 09 2.8%
12/23 Form 4 BIOMERICA INC For: Dec 19 Filed by: BARBIERI ALLEN 2.7%
3/22 Labs race to produce tests that show where COVID-19 has already been [Toronto Globe and Mail (Ontario, Canada)] 35.8%
10/15 Q1/2020 8/31/2019 EPS -0.050 ZacksConsensus -0.060 ActVsEst 0.010 - Beat 9.7%
6/5 Biomerica signs exclusive distribution agreement in China for its colorectal screening test with total minimum purchase requirement of $17 million over 7 years and an upfront pre-payment of $1 million. 8.0%
3/4 Form SC 13D BIOMERICA INC Filed by: Palm Management (US) LLC 6.1%
9/11 Biomerica, Inc. (NASDAQ: BMRA) was given a new $6.00 price target on by analysts at B. Riley. They now have a "buy" rating on the stock. 6.1%
12/30 Biomerica, Inc. (NASDAQ: BMRA) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 5.4%
4/3 Form 4 BIOMERICA INC For: Apr 01 Filed by: BARBIERI ALLEN 3.0%
1/9 Form 8-K BIOMERICA INC For: Jan 09 2.8%
12/23 Form 4 BIOMERICA INC For: Dec 19 Filed by: BARBIERI ALLEN 2.7%
TOP News Decliners
3/20
Form 424B5 BIOMERICA INC
-41.5%
6/5 Form 8-K BIOMERICA INC For: May 31 -8.8%
4/2 A coronavirus immunity test is essential for the U.S. But will it work? [Los Angeles Times (CA)] -7.6%
3/25 U.S. companies, labs rush to produce blood test for coronavirus immunity [Reuters] -7.3%
3/2 Form 4 BIOMERICA INC For: Feb 28 Filed by: Irani Zackary S. -5.8%
1/14 Form 10-Q BIOMERICA INC For: Nov 30 -5.4%
11/7 Biomerica, Inc. (NASDAQ: BMRA) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -4.5%
4/14 Form 10-Q BIOMERICA INC For: Feb 29 -3.8%
4/21 Form 4 BIOMERICA INC For: Apr 17 Filed by: Sirgo Mark A -3.0%
4/6 Form 8-K BIOMERICA INC For: Apr 01 -1.3%
6/5 Form 8-K BIOMERICA INC For: May 31 -8.8%
4/2 A coronavirus immunity test is essential for the U.S. But will it work? [Los Angeles Times (CA)] -7.6%
3/25 U.S. companies, labs rush to produce blood test for coronavirus immunity [Reuters] -7.3%
3/2 Form 4 BIOMERICA INC For: Feb 28 Filed by: Irani Zackary S. -5.8%
1/14 Form 10-Q BIOMERICA INC For: Nov 30 -5.4%
11/7 Biomerica, Inc. (NASDAQ: BMRA) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -4.5%
4/14 Form 10-Q BIOMERICA INC For: Feb 29 -3.8%
4/21 Form 4 BIOMERICA INC For: Apr 17 Filed by: Sirgo Mark A -3.0%
4/6 Form 8-K BIOMERICA INC For: Apr 01 -1.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: